• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.60% Nasdaq Down0.39%

    Achillion Pharmaceuticals, Inc. (ACHN)

    -NasdaqGS
    5.63 Down 0.29(4.90%) Feb 11, 4:00PM EST
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
    Total Revenue 33,820   711   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit 33,820   711   -   -  
    Operating Expenses
    Research Development11,984  19,772  15,156  16,426  
    Selling General and Administrative4,856  10,127  4,243  5,235  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 16,980   (29,188) (19,399) (21,661)
    Income from Continuing Operations
    Total Other Income/Expenses Net9,290  225  152  79  
    Earnings Before Interest And Taxes26,270  (28,963)(19,247)(21,582)
    Interest Expense11  15  16  14  
    Income Before Tax26,259  (28,978)(19,263)(21,596)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops26,259  (28,978)(19,263)(21,596)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 26,259   (28,978) (19,263) (21,596)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 26,259   (28,978) (19,263) (21,596)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.